Horizon Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.6M | Buy |
244,041
+126,052
| +107% | +$7.35M | 0.16% | 104 |
|
|
2025
Q4 | $6.29M | Sell |
117,989
-137,701
| -54% | -$6.62M | 0.08% | 216 |
|
|
2025
Q3 | $11.4M | Sell |
255,690
-1,171
| -0.5% | -$54.7K | 0.15% | 116 |
|
|
2025
Q2 | $11.7M | Buy |
256,861
+205,485
| +400% | +$10.1M | 0.19% | 86 |
|
|
2025
Q1 | $3.1M | Buy |
51,376
+1,349
| +3% | +$78.6K | 0.09% | 139 |
|
|
2024
Q4 | $2.8M | Buy |
50,027
+1,503
| +3% | +$84K | 0.08% | 150 |
|
|
2024
Q3 | $2.48M | Buy |
48,524
+15,432
| +47% | +$724K | 0.07% | 146 |
|
|
2024
Q2 | $1.35M | Sell |
33,092
-380
| -1% | -$17K | 0.04% | 219 |
|
|
2024
Q1 | $1.79M | Buy |
33,472
+9,438
| +39% | +$481K | 0.05% | 180 |
|
|
2023
Q4 | $1.22M | Sell |
24,034
-27,927
| -54% | -$1.47M | 0.03% | 207 |
|
|
2023
Q3 | $2.99M | Sell |
51,961
-184
| -0.4% | -$11.3K | 0.09% | 94 |
|
|
2023
Q2 | $3.31M | Buy |
52,145
+2,936
| +6% | +$197K | 0.1% | 89 |
|
|
2023
Q1 | $3.38M | Sell |
49,209
-9,532
| -16% | -$672K | 0.1% | 81 |
|
|
2022
Q4 | $4.19M | Sell |
58,741
-37,907
| -39% | -$2.86M | 0.12% | 83 |
|
|
2022
Q3 | $6.82M | Buy |
96,648
+58,939
| +156% | +$4.28M | 0.21% | 49 |
|
|
2022
Q2 | $2.9M | Sell |
37,709
-60,539
| -62% | -$4.61M | 0.09% | 88 |
|
|
2022
Q1 | $7.17M | Buy |
98,248
+30,655
| +45% | +$2.06M | 0.2% | 57 |
|
|
2021
Q4 | $4.18M | Buy |
67,593
+4,147
| +7% | +$243K | 0.12% | 89 |
|
|
2021
Q3 | $3.75M | Sell |
63,446
-40,128
| -39% | -$2.64M | 0.1% | 99 |
|
|
2021
Q2 | $6.87M | Buy |
103,574
+43,010
| +71% | +$2.8M | 0.2% | 58 |
|
|
2021
Q1 | $3.82M | Buy |
+60,564
| New | +$3.77M | 0.14% | 66 |
|
|
2020
Q4 | – | Sell |
-47,307
| Closed | -$2.83M | – | 119 |
|
|
2020
Q3 | $2.83M | Sell |
47,307
-76,825
| -62% | -$4.62M | 0.1% | 95 |
|
|
2020
Q2 | $7.24M | Buy |
124,132
+83,161
| +203% | +$4.97M | 0.18% | 59 |
|
|
2020
Q1 | $2.27M | Sell |
40,971
-54,991
| -57% | -$3.36M | 0.11% | 70 |
|
|
2019
Q4 | $6.16M | Sell |
95,962
-8,124
| -8% | -$465K | 0.27% | 51 |
|
|
2019
Q3 | $5.23M | Buy |
104,086
+78,331
| +304% | +$3.68M | 0.21% | 53 |
|
|
2019
Q2 | $1.17M | Buy |
25,755
+19,894
| +339% | +$927K | 0.03% | 117 |
|
|
2019
Q1 | $277K | Buy |
+5,861
| New | +$292K | 0.01% | 279 |
|
|
2018
Q2 | – | Sell |
-16,287
| Closed | -$1.03M | – | 241 |
|
|
2018
Q1 | $1.03M | Buy |
+16,287
| New | +$1.05M | 0.04% | 117 |
|
|
2017
Q1 | – | Sell |
-5,870
| Closed | -$343K | – | 157 |
|
|
2016
Q4 | $343K | Buy |
+5,870
| New | +$321K | 0.02% | 143 |
|
Other funds holding BMY
VCM
VPM
Horizon Investments's BMY Position: Q1 2026 in Review
Horizon Investments increased its Bristol-Myers Squibb (BMY) stake by 107% in Q1 2026, buying an estimated $7.35M and bringing the position to 244,041 shares worth $14.6M. The position accounts for 0.16% of the portfolio, ranked #104.
Horizon Investments first reported a position in BMY in Q4 2016 and has held it in 30 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Horizon Investments held 244,041 shares of Bristol-Myers Squibb worth $14.6M as of Q1 2026.
- Horizon Investments bought 126,052 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.35M.
- Bristol-Myers Squibb made up 0.16% of Horizon Investments's portfolio in Q1 2026, its #104 holding.
- Horizon Investments first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 30 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.